metronidazole has been researched along with Cholera Infantum in 71 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the safety and efficacy of cefepime hydrochloride plus metronidazole vs the combination of imipenem and cilastatin sodium in the treatment of complicated intra-abdominal infections in adult patients." | 9.08 | A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. ( Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY, 1997) |
| " Through the Cockayne Syndrome Natural History Study, we have identified 8 cases of acute hepatic failure after metronidazole administration (8% of our cohort), 3 of which were fatal." | 7.81 | Metronidazole Toxicity in Cockayne Syndrome: A Case Series. ( Munkley, J; O'Kelly, S; Stark, Z; Strong, A; Wilson, BT, 2015) |
| "Metronidazole was administered (500 mg daily the first month, 250 mg daily the second month and, in some cases, 250 mg every other day the following months) to 62 patients suffering from rosacea or perioral dermatitis." | 7.66 | [Metronidazole therapy in rosacea (author's transl)]. ( Guilhou, E; Guilhou, JJ; Malbos, S; Meynadier, J, 1979) |
| "To evaluate the safety and efficacy of cefepime hydrochloride plus metronidazole vs the combination of imipenem and cilastatin sodium in the treatment of complicated intra-abdominal infections in adult patients." | 5.08 | A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. ( Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY, 1997) |
| " pylori-positive peptic ulcer received lansoprazole 30 mg twice daily in combination with metronidazole 400 mg twice daily and clarithromycin 250 mg twice daily for 5 days." | 5.08 | Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough? ( Cunnane, K; Kelly, S; Laundon, J; McLoughlin, R; O'Connor, HJ, 1998) |
| " Metronidazole resistance in peptic ulcer patients was significantly higher." | 3.83 | A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis. ( Bian, H; Fang, Y; Hu, B; Kong, M; Miao, Y; Olszewski, MA; Wang, S; Wu, Y; Xu, L; Yang, C; Zhang, Y; Zhao, F; Zhao, H, 2016) |
| " Through the Cockayne Syndrome Natural History Study, we have identified 8 cases of acute hepatic failure after metronidazole administration (8% of our cohort), 3 of which were fatal." | 3.81 | Metronidazole Toxicity in Cockayne Syndrome: A Case Series. ( Munkley, J; O'Kelly, S; Stark, Z; Strong, A; Wilson, BT, 2015) |
| "Metronidazole was administered (500 mg daily the first month, 250 mg daily the second month and, in some cases, 250 mg every other day the following months) to 62 patients suffering from rosacea or perioral dermatitis." | 3.66 | [Metronidazole therapy in rosacea (author's transl)]. ( Guilhou, E; Guilhou, JJ; Malbos, S; Meynadier, J, 1979) |
| "-infected individuals, who presented increased parasite load and exacerbated symptoms upon treatment with the usual recommended dosage and regime of metronidazole." | 1.48 | Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies. ( Kudva, M; Kumar, S; Rajamanikam, A; Samudi, C, 2018) |
| "Oral metronidazole treatments were administered to the patients." | 1.48 | Three Pentatrichomonas hominis Cases Presenting with Gastrointestinal Symptoms. ( Doğan, N; Tüzemen, NÜ, 2018) |
| "Chronic urticaria is a disease of unknown etiology." | 1.29 | [Connection between Helicobacter pylori infection and chronic gastrointestinal urticaria]. ( Daróczy, J; Ferenczi, K; Kalas, D; Pálos, G; Prónai, L, 1996) |
| "Metronidazole was always used in combination with other antimicrobial drugs." | 1.28 | Clinical use of metronidazole in horses: 200 cases (1984-1989). ( Sweeney, CR; Sweeney, RW; Weiher, J, 1991) |
| "Metronidazole also has been used either alone or in combination, most frequently with amoxicillin, to treat many other anaerobic infections: head and neck, pleuropulmonary, genital tract, bone and joint, skin and soft tissue, and cases of fusobacterial septicemia (necrobacillosis)." | 1.27 | The therapeutic use of metronidazole in anaerobic infection: six years' experience in a London hospital. ( Eykyn, SJ, 1983) |
| "Giardiasis is a common infection, and many of its symptoms are similar to those of Crohn's disease." | 1.27 | Crohn's disease is frequently complicated by giardiasis. ( Kruis, W; Lamina, J; Paumgartner, G; Scheurlen, C; Spengler, U; Weinzierl, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (32.39) | 18.7374 |
| 1990's | 18 (25.35) | 18.2507 |
| 2000's | 12 (16.90) | 29.6817 |
| 2010's | 15 (21.13) | 24.3611 |
| 2020's | 3 (4.23) | 2.80 |
| Authors | Studies |
|---|---|
| Cobuccio, LG | 3 |
| Laurent, M | 3 |
| Gardiol, C | 3 |
| Wampfler, R | 3 |
| Poppert, S | 3 |
| Senn, N | 3 |
| Eperon, G | 3 |
| Genton, B | 3 |
| Locatelli, I | 3 |
| de Vallière, S | 3 |
| Leite, S | 1 |
| Cotias, C | 1 |
| Rainha, KC | 1 |
| Santos, MG | 1 |
| Penna, B | 1 |
| F Moraes, RF | 1 |
| Harmanus, C | 1 |
| Smits, WK | 1 |
| Ferreira, EO | 1 |
| Nyssen, OP | 1 |
| Perez-Aisa, A | 1 |
| Castro-Fernandez, M | 1 |
| Pellicano, R | 1 |
| Huguet, JM | 1 |
| Rodrigo, L | 1 |
| Ortuñ, J | 1 |
| Gomez-Rodriguez, BJ | 1 |
| Pinto, RM | 1 |
| Areia, M | 1 |
| Perona, M | 1 |
| Nuñez, O | 1 |
| Romano, M | 1 |
| Gravina, AG | 1 |
| Pozzati, L | 1 |
| Fernandez-Bermejo, M | 1 |
| Venerito, M | 1 |
| Malfertheiner, P | 1 |
| Fernanadez-Salazar, L | 1 |
| Gasbarrini, A | 1 |
| Vaira, D | 1 |
| Puig, I | 1 |
| Megraud, F | 1 |
| O'Morain, C | 1 |
| Gisbert, JP | 1 |
| Okamoto, K | 1 |
| Watanabe, T | 1 |
| Komeda, Y | 1 |
| Okamoto, A | 1 |
| Minaga, K | 1 |
| Kamata, K | 1 |
| Yamao, K | 1 |
| Takenaka, M | 1 |
| Hagiwara, S | 1 |
| Sakurai, T | 1 |
| Tanaka, T | 1 |
| Sakamoto, H | 1 |
| Fujimoto, K | 1 |
| Nishida, N | 1 |
| Kudo, M | 1 |
| Rajamanikam, A | 1 |
| Kumar, S | 1 |
| Samudi, C | 1 |
| Kudva, M | 1 |
| Doğan, N | 1 |
| Tüzemen, NÜ | 1 |
| Whittemore, JC | 1 |
| Moyers, TD | 1 |
| Price, JM | 1 |
| de Jong, MJ | 1 |
| Korterink, JJ | 1 |
| Benninga, MA | 1 |
| Hilbink, M | 1 |
| Widdershoven, J | 1 |
| Deckers-Kocken, JM | 1 |
| Soriano, MM | 1 |
| Johnson, S | 1 |
| Wilson, BT | 1 |
| Strong, A | 1 |
| O'Kelly, S | 1 |
| Munkley, J | 1 |
| Stark, Z | 1 |
| Asif, HM | 1 |
| Zaidi, SF | 1 |
| Sugiyama, T | 1 |
| Akhtar, N | 1 |
| Usmanghani, K | 1 |
| Hu, B | 1 |
| Zhao, F | 1 |
| Wang, S | 1 |
| Olszewski, MA | 1 |
| Bian, H | 1 |
| Wu, Y | 1 |
| Kong, M | 1 |
| Xu, L | 1 |
| Miao, Y | 1 |
| Fang, Y | 1 |
| Yang, C | 1 |
| Zhao, H | 1 |
| Zhang, Y | 1 |
| Salvador, F | 1 |
| Sulleiro, E | 1 |
| Sánchez-Montalvá, A | 1 |
| Alonso, C | 1 |
| Santos, J | 1 |
| Fuentes, I | 1 |
| Molina, I | 1 |
| Zuccoli, G | 1 |
| Pipitone, N | 1 |
| Santa Cruz, D | 1 |
| Weiss, G | 1 |
| Reimnitz, P | 1 |
| Hampel, B | 1 |
| Muehlhofer, E | 1 |
| Lippert, H | 1 |
| Pontone, S | 1 |
| Standoli, M | 1 |
| Angelini, R | 1 |
| Pontone, P | 1 |
| Towfigh, S | 1 |
| Pasternak, J | 1 |
| Poirier, A | 1 |
| Leister, H | 1 |
| Babinchak, T | 1 |
| Yakoob, J | 1 |
| Abid, S | 1 |
| Abbas, Z | 1 |
| Jafri, SN | 1 |
| Peel, T | 1 |
| Cheng, AC | 1 |
| Spelman, T | 1 |
| Huysmans, M | 1 |
| Spelman, D | 1 |
| Higashida, A | 1 |
| Mamori, S | 1 |
| Kuwada, T | 1 |
| Mitsuoka, T | 1 |
| Taki, M | 1 |
| Suga, Y | 1 |
| Senda, E | 1 |
| Ashida, C | 1 |
| Yamada, H | 1 |
| Barie, PS | 2 |
| Rotstein, OD | 2 |
| Dellinger, EP | 2 |
| Grasela, TH | 1 |
| Walawander, CA | 1 |
| Saad, R | 1 |
| Chey, WD | 1 |
| Konno, M | 1 |
| Garbino, J | 1 |
| Villiger, P | 1 |
| Caviezel, A | 1 |
| Matulionyte, R | 1 |
| Uckay, I | 1 |
| Morel, P | 1 |
| Lew, D | 1 |
| Dovzhanskiĭ, SI | 1 |
| Grashkina, IG | 1 |
| Iaksanova, EM | 1 |
| Richter, R | 1 |
| Eykyn, SJ | 1 |
| Baines, EJ | 1 |
| McFadzean, JA | 1 |
| Sazhin, VP | 1 |
| Korovin, AIa | 1 |
| Sorokin, VM | 1 |
| Sypchenko, AIa | 1 |
| Schweizer, W | 1 |
| Striffeler, H | 1 |
| Lüdi, D | 1 |
| Fröscher, R | 1 |
| Logan, RP | 1 |
| Gummett, PA | 1 |
| Misiewicz, JJ | 1 |
| Karim, QN | 1 |
| Walker, MM | 1 |
| Baron, JH | 1 |
| Byl, B | 1 |
| Jacobs, F | 1 |
| Struelens, MJ | 1 |
| Thys, JP | 1 |
| Kalas, D | 1 |
| Prónai, L | 1 |
| Ferenczi, K | 1 |
| Pálos, G | 1 |
| Daróczy, J | 1 |
| Seifrit, B | 1 |
| Taylor, AP | 1 |
| Davis, LJ | 1 |
| Soave, R | 1 |
| Schwartz, H | 1 |
| Krause, R | 1 |
| Siepman, N | 1 |
| Haber, M | 1 |
| Weissfeld, A | 1 |
| Kidd, S | 1 |
| Rose, P | 1 |
| Sahba, B | 1 |
| Vogel, SB | 1 |
| Solomkin, JS | 1 |
| Yang, JY | 1 |
| Baumgartner, TF | 1 |
| O'Connor, HJ | 1 |
| McLoughlin, R | 1 |
| Kelly, S | 1 |
| Laundon, J | 1 |
| Cunnane, K | 1 |
| Kasperk, R | 1 |
| Riesener, KP | 1 |
| Schumpelick, V | 1 |
| Ghosh, K | 1 |
| Ayyaril, M | 1 |
| Nirmala, V | 1 |
| Henry, A | 1 |
| Batey, RG | 1 |
| Unge, P | 1 |
| van der Hulst, RW | 1 |
| van 't Hoff, BW | 1 |
| van der Ende, A | 1 |
| Tytgat, GN | 1 |
| Reiss, M | 1 |
| Reiss, G | 1 |
| Rasmussen, IC | 1 |
| Odenholt, I | 1 |
| Raab, Y | 1 |
| Hunt, RH | 1 |
| Smaill, FM | 1 |
| Fallone, CA | 1 |
| Sherman, PM | 1 |
| Veldhuyzen van Zanten, SJ | 1 |
| Thomson, AB | 1 |
| Hanson, JM | 1 |
| McGregor, JA | 1 |
| Hillier, SL | 1 |
| Eschenbach, DA | 1 |
| Kreutner, AK | 1 |
| Galask, RP | 1 |
| Martens, M | 1 |
| Pilotto, A | 1 |
| Franceschi, M | 1 |
| Rassu, M | 1 |
| Leandro, G | 1 |
| Bozzola, L | 1 |
| Furlan, F | 1 |
| Di Mario, F | 1 |
| Maev, IV | 1 |
| V'iuchnova, ES | 1 |
| Lebedev, EG | 1 |
| Dicheva, DT | 1 |
| Ovsiannikova, EV | 1 |
| Antonenko, OM | 1 |
| Shchekina, MI | 1 |
| Guilhou, JJ | 1 |
| Guilhou, E | 1 |
| Malbos, S | 1 |
| Meynadier, J | 1 |
| Fleischer, NK | 1 |
| Strik, WO | 1 |
| Spencer, MJ | 1 |
| Garcia, LS | 1 |
| Chapin, MR | 1 |
| Peled, Y | 1 |
| Levy-Gigi, C | 1 |
| Ayalon, D | 1 |
| Gilat, T | 1 |
| Sprott, MS | 1 |
| Ingham, HR | 1 |
| Ochs, HD | 1 |
| Ament, ME | 2 |
| Davis, SD | 1 |
| Lebreton, JM | 1 |
| Seppälä, K | 1 |
| Berstad, K | 1 |
| Weberg, R | 1 |
| Berstad, A | 1 |
| Chappell, CL | 1 |
| Matson, CC | 1 |
| Sweeney, RW | 1 |
| Sweeney, CR | 1 |
| Weiher, J | 1 |
| Sun, T | 1 |
| Katz, S | 1 |
| Tanenbaum, B | 1 |
| Schenone, C | 1 |
| Bromiker, R | 1 |
| Korman, SH | 1 |
| Or, R | 1 |
| Hardan, I | 1 |
| Naparstek, E | 1 |
| Cohen, P | 1 |
| Ben-Shahar, M | 1 |
| Engelhard, D | 1 |
| Cann, KJ | 1 |
| Watkins, RM | 1 |
| George, C | 1 |
| Payne-James, J | 1 |
| Crawfurd, E | 1 |
| Rogers, TR | 1 |
| Scheurlen, C | 1 |
| Kruis, W | 1 |
| Spengler, U | 1 |
| Weinzierl, M | 1 |
| Paumgartner, G | 1 |
| Lamina, J | 1 |
| Guirges, SY | 1 |
| Al-Waili, NS | 1 |
| Kale, OO | 1 |
| Rubin, CE | 1 |
| Petersen, H | 1 |
| de Mattos, H | 1 |
| Alp, MH | 1 |
| Hislop, IG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| European Registry on the Management of Helicobacter Pylori Infection[NCT02328131] | 10,000 participants (Anticipated) | Observational | 2013-06-30 | Recruiting | |||
| A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment[NCT02978157] | 102 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial[NCT02547012] | 51 participants (Actual) | Interventional | 2013-11-30 | Completed | |||
| A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection[NCT00195351] | Phase 4 | 467 participants (Actual) | Interventional | 2005-09-30 | Completed | ||
| Rifaximin Associated With Classic Triple Therapy (Inhibitor of Proton Pump, Amoxicillin and Clarithromycin) for the Eradication of Helicobacter Pylori Infection[NCT03124199] | Phase 3 | 40 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants with negative H pylori status in follow-up tests as a measure of successful eradication (NCT02978157)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo | 36 |
| Esomeprazole+Bismuth+Tetra+Levo | 49 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02547012)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo+Tetra | 13 |
| Esomeprazole+Amox+Levo | 21 |
The clinical response was assigned by the investigator according to the protocol-specified guidelines. A clinical response of cure was defined as: the test article and the initial intervention (operative and/or radiologically controlled drainage procedure) resolved the intra-abdominal infection. (NCT00195351)
Timeframe: 10-21 days after the last dose of test article
| Intervention | participants (Number) |
|---|---|
| Tigecycline | 133 |
| Ceftriaxone Sodium + Metronidazole | 139 |
The clinical response was assigned by the investigator according to the protocol-specified guidelines. A clinical response of cure was defined as: the test article and the initial intervention (operative and/or radiologically controlled drainage procedure) resolved the intra-abdominal infection. (NCT00195351)
Timeframe: 10-21 days after the last dose of test article
| Intervention | participants (Number) |
|---|---|
| Tigecycline | 91 |
| Ceftriaxone Sodium + Metronidazole | 96 |
Microbiologic response assessed at patient level was combined microbiologic responses for all baseline isolates identified in intra-abdominal/blood cultures. Eradication=baseline isolate not recovered from primary infection site/blood; Presumed Eradication=no material available for culture but response was cure; Persistence=baseline isolate recovered from primary infection site/blood; Presumed Persistence=no material available for culture but response was failure; Superinfection=culture from primary infection site was positive for new isolate not identified at baseline & response was failure. (NCT00195351)
Timeframe: 10-21 days after the last dose of test article
| Intervention | participants (Number) | ||
|---|---|---|---|
| Eradication and presumed eradication | Persistence and presumed persistence | Superinfection | |
| Ceftriaxone Sodium + Metronidazole | 98 | 39 | 3 |
| Tigecycline | 94 | 44 | 7 |
Percentage of patients that has comply with treatment, considered as intake of more than 90% of study drugs in patients who attended the post-treatment visit. (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 100 |
Percentage of Participants with H.Pylori Infection Eradication confirmed with urea breath test at least 4 weeks after the end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 61 |
Patients with side effects present during treatment and in the 4 weeks after end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| with diarrhea | with metallic taste | headache | nausea | abdominal pain | |
| Rifaximin | 13 | 9 | 5 | 5 | 1 |
13 reviews available for metronidazole and Cholera Infantum
| Article | Year |
|---|---|
Treatment of Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Admin | 2015 |
A clinician's guide to managing Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Endoscopy; Gastrointestinal | 2005 |
[Helicobacter pylori eradication therapy for children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents | 2005 |
The action of metronidazole on anaerobic bacilli and similar organisms.
Topics: Administration, Oral; Anaerobiosis; Animals; Bacteria; Bacterial Infections; Bacteroides Infections; | 1981 |
Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; | 1997 |
Cyclospora.
Topics: Animals; Anti-Infective Agents; Antitrichomonal Agents; Ciprofloxacin; Coccidiosis; Eucoccidiida; Ga | 1997 |
Antibiotic treatment of Helicobacter pylori infection.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Di | 1999 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Fema | 1999 |
[Bad breath--etiological, diagnostic and therapeutic problems].
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Gastrointestinal Diseases; Halitosis; Humans; Lung D | 2000 |
Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Gastrointestinal Diseases; Helico | 2000 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double | 2001 |
[Lambliasis. Pathogenicity, clinical picture, diagnosis and therapy].
Topics: Chloroquine; Diarrhea; England; Female; Gastrointestinal Diseases; Germany; Giardia; Giardiasis; Hum | 1978 |
[Should Helicobacter infection be treated?].
Topics: Ampicillin; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infe | 1991 |
16 trials available for metronidazole and Cholera Infantum
| Article | Year |
|---|---|
Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Topics: Adult; Animals; Blastocystis; Blastocystis Infections; Feces; Gastrointestinal Diseases; Humans; Met | 2023 |
Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Topics: Adult; Animals; Blastocystis; Blastocystis Infections; Feces; Gastrointestinal Diseases; Humans; Met | 2023 |
Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Topics: Adult; Animals; Blastocystis; Blastocystis Infections; Feces; Gastrointestinal Diseases; Humans; Met | 2023 |
Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Topics: Adult; Animals; Blastocystis; Blastocystis Infections; Feces; Gastrointestinal Diseases; Humans; Met | 2023 |
Randomized, controlled, crossover trial of prevention of antibiotic-induced gastrointestinal signs using a synbiotic mixture in healthy research dogs.
Topics: Animals; Anti-Bacterial Agents; Cross-Over Studies; Dog Diseases; Dogs; Eating; Enrofloxacin; Female | 2019 |
Phytomedicine-based and Quadruple Therapies in Helicobacter pylori Infection: A Comparative, Randomized Trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Com | 2015 |
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).
Topics: Abdominal Abscess; Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; | 2009 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 2010 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 2010 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 2010 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 2010 |
A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections.
Topics: Abdomen; Anti-Infective Agents; Bacteria; Bacterial Infections; Ceftriaxone; Drug Therapy, Combinati | 2010 |
A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
Topics: Abdominal Cavity; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infection | 2007 |
["Single shot" prevention in abdominal surgery. Antibiotics with long half-life (ceftriaxone, ornidazole) vs. antibiotics with short half-life (cefazolin, metronidazole, clindamycin)].
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Cross Infection; Double-Bli | 1994 |
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Clarithromycin; Diarrhea; Drug Administration | 1996 |
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalospor | 1997 |
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial | 1998 |
Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, | 1999 |
Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Female | 2000 |
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, | 2000 |
A trial of mezlocillin versus cefuroxime with or without metronidazole for the prevention of wound sepsis after biliary and gastrointestinal surgery.
Topics: Biliary Tract Diseases; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Drug Therapy, Combinat | 1988 |
A controlled field trial of the treatment of dracontiasis with metronidazole and niridazole.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dracunculiasis; Gastrointestinal Diseases; Humans; | 1974 |
42 other studies available for metronidazole and Cholera Infantum
| Article | Year |
|---|---|
Prevalence of Clostridioides difficile in dogs (Canis familiaris) with gastrointestinal disorders in Rio de Janeiro.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Brazil; Clostridioides; Clostridioides difficile; | 2023 |
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bismuth; Capsules; Drug Combinations; Drug Resistance, Bac | 2021 |
Dysbiosis-Associated Polyposis of the Colon-Cap Polyposis.
Topics: Ampicillin; Anti-Bacterial Agents; Asymptomatic Diseases; Bacteria; Colon; Colonic Polyps; Dysbiosis | 2018 |
Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.
Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Blastocystis; Blastocystis Infections; Drug Resist | 2018 |
Three Pentatrichomonas hominis Cases Presenting with Gastrointestinal Symptoms.
Topics: Administration, Oral; Aged; Animals; Antitrichomonal Agents; Child; Diagnosis, Differential; Diarrhe | 2018 |
Dientamoeba fragilis and chronic abdominal pain in children: a case-control study.
Topics: Abdominal Pain; Adolescent; Antiprotozoal Agents; Case-Control Studies; Child; Chronic Disease; Clio | 2014 |
Metronidazole Toxicity in Cockayne Syndrome: A Case Series.
Topics: Adolescent; Anti-Infective Agents; Cockayne Syndrome; Fatal Outcome; Female; Gastrointestinal Diseas | 2015 |
A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Base Sequence; Biopsy; China; DNA Mutational | 2016 |
Epidemiological and clinical profile of adult patients with Blastocystis sp. infection in Barcelona, Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Asymptomatic Infections; Blastocys | 2016 |
Metronidazole-induced and Wernicke encephalopathy: two different entities sharing the same metabolic pathway?
Topics: Anti-Infective Agents; Brain; Cerebellar Nuclei; Dominance, Cerebral; Gastrointestinal Diseases; Hum | 2008 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resis | 2010 |
Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Topics: Adult; Age Factors; Aged; Bacteremia; Bone Marrow Transplantation; Case-Control Studies; Catheteriza | 2012 |
Effectiveness of esomeprazole-based triple therapy of H. pylori in young patients in Japan.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Coh | 2013 |
The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection.
Topics: Adult; Aged; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cost-Benefit Analys | 2004 |
[Pathogenesis and treatment of rosacea and perioral dermatitis].
Topics: Adolescent; Adult; Aged; Calcium Gluconate; Drug Therapy, Combination; Facial Dermatoses; Female; Ga | 1980 |
Conventional therapy of trichomoniasis.
Topics: Antitrichomonal Agents; Female; Gastrointestinal Diseases; Humans; Metronidazole; Ornidazole; Pregna | 1983 |
The therapeutic use of metronidazole in anaerobic infection: six years' experience in a London hospital.
Topics: Adult; Aged; Bacterial Infections; Bone Diseases; Empyema; Female; Fusobacterium Infections; Gastroi | 1983 |
Symposium on metronidazole against anaerobic infections. Solstrand Fjordhotel, 2-3 March, 1979.
Topics: Anaerobiosis; Bacterial Infections; Gastrointestinal Diseases; Male; Metronidazole; Surgical Wound I | 1980 |
[Metronidazole in prevention and treatment of wound infection].
Topics: Escherichia coli Infections; Gastrointestinal Diseases; Humans; Metronidazole; Surgical Wound Infect | 1981 |
Two-week eradication regimen for metronidazole-resistant Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Ciprofloxacin; Drug Resistanc | 1993 |
Extraintestinal Clostridium difficile infections.
Topics: Adolescent; Aged; Anti-Bacterial Agents; Antitrichomonal Agents; Bacteremia; Ceftazidime; Cephalospo | 1996 |
[Connection between Helicobacter pylori infection and chronic gastrointestinal urticaria].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Bismuth; Chronic Disease; Female; | 1996 |
[Perioperative antibiotic prophylaxis in visceral surgery--pro and contra].
Topics: Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gastrointestinal | 1997 |
Acute GVHD involving the gastrointestinal tract and infestation with Blastocystis hominis in a patient with chronic myeloid leukaemia following allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Animals; Antiprotozoal Agents; Blastocystis hominis; Blastocystis Infections; | 1998 |
[Peroral antibiotic prophylaxis in upper gastrointestinal surgery. A study of biological availability].
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Biological Availab | 2000 |
[Metronidazole therapy in rosacea (author's transl)].
Topics: Adult; Aged; Dermatitis; Female; Gastrointestinal Diseases; Humans; Male; Metronidazole; Middle Aged | 1979 |
Dientamoeba fragilis. An intestinal pathogen in children?
Topics: Amebiasis; Child; Child, Preschool; Dientamoebiasis; Female; Gastrointestinal Diseases; Humans; Infa | 1979 |
The cholyl glycine-1-14C breath test in various gastrointestinal disorders.
Topics: Adolescent; Adult; Aged; Breath Tests; Cholecystectomy; False Negative Reactions; Feces; Female; Gas | 1979 |
Treatment of infections due to nonsporing anaerobes.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Brain Diseases; Cefoxitin; Clindamycin; G | 1979 |
Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes (IDS) and in granulocyte dysfunction.
Topics: Carotenoids; Crohn Disease; Digestive System; Disaccharidases; Feces; Female; Folic Acid; Gastrointe | 1975 |
[New therapeutic developments in gastroenterology].
Topics: Amebiasis; Atropa belladonna; Gastrointestinal Diseases; Metronidazole; Peptic Ulcer; Phytotherapy; | 1975 |
Is there a place for antacids in the treatment of Helicobacter pylori infection?
Topics: Adult; Aluminum Hydroxide; Antacids; Breath Tests; Carbonates; Clinical Enzyme Tests; Drug Therapy, | 1992 |
Giardia antigen detection in patients with chronic gastrointestinal disturbances.
Topics: Adult; Aged; Animals; Antigens, Protozoan; Child; Chronic Disease; Costs and Cost Analysis; Enzyme-L | 1992 |
Clinical use of metronidazole in horses: 200 cases (1984-1989).
Topics: Animals; Bacteria, Anaerobic; Bacterial Infections; Bacteroides Infections; Drug Therapy, Combinatio | 1991 |
Questionable clinical significance of Blastocystis hominis infection.
Topics: Adult; Animals; Eukaryota; Feces; Female; Gastrointestinal Diseases; Humans; Male; Metronidazole; Mi | 1989 |
Severe giardiasis in two patients undergoing bone marrow transplantation.
Topics: Adult; Anemia, Aplastic; Animals; Bone Marrow Transplantation; Gastrointestinal Diseases; Giardia; G | 1989 |
Crohn's disease is frequently complicated by giardiasis.
Topics: Adult; Aged; Crohn Disease; Feces; Female; Gastrointestinal Diseases; Giardiasis; Humans; Male; Metr | 1988 |
Blastocystis hominis: evidence for human pathogenicity and effectiveness of metronidazole therapy.
Topics: Adolescent; Adult; Aged; Child; Entomophthora; Female; Fungi; Gastrointestinal Diseases; Humans; Int | 1987 |
Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes.
Topics: Adult; Agammaglobulinemia; Celiac Disease; Duodenum; Female; Gastrointestinal Diseases; Giardiasis; | 1972 |
Giardiasis (lambliasis).
Topics: Adolescent; Adult; Aged; Animals; Diarrhea; Duodenum; Feces; Female; Gastric Juice; Gastrointestinal | 1972 |
[Relations between alcoholism and the gastrointestinal system. Experience using Metronidazole].
Topics: Adolescent; Adult; Alcoholism; Child; Ethanol; Gastrointestinal Diseases; Humans; Metronidazole; Mid | 1968 |
Giardia lamblia infestation: a report of five adult cases.
Topics: Adult; Gastrointestinal Diseases; Giardiasis; Humans; Intestinal Absorption; Metronidazole; Quinacri | 1969 |